Skip to main content

Table 9 Adjusted associations between selected variables and the mean head circumference (HC) of newborns, between April and November 2015

From: Scaling-up the use of sulfadoxine-pyrimethamine for the preventive treatment of malaria in pregnancy: results and lessons on scalability, costs and programme impact from three local government areas in Sokoto State, Nigeria

 

Estimate

Standard error

Pr > |t|

Intercept

363.78

2.77

<0.0001

Sex of infant

 Female

−2.33

0.55

<0.0001

 Male (ref)

   

Intervention

 Yes

2.88

0.66

<0.0001

 No (ref)

   

SP dosage

 0

−2.87

0.87

0.00

 1

−1.88

0.93

0.04

 2

−2.55

0.78

0.00

 3+ (ref)

   

Primigravida

 Yes

−1.16

0.71

0.10

 No (ref)

   

At least 1 ANC visit

 Yes

2.01

0.62

0.00

 No (ref)

 Month of birth

−0.64

0.13

<0.0001

Gestational age at delivery (months)

 8

−17.83

5.68

0.00

 9 

−3.73

2.14

0.08

 10 (ref)

   
  1. n = 6702; F test p < 0.0001; Adj. r-square 0.017; RMSE: 22.6